Medical/Pharmaceuticals

Viva Biotech Secures Approximately US$ 210 Million Funding

HONG KONG, Nov. 20, 2023 /PRNewswire/ -- On November 20, 2023, Viva Biotech Holdings Group (1873. HK) announced thatit completed a funding round, securing approximatelyUS$210 million and bringing in the strategic investors, Temasek, Highlight Capital (HLC), and True Light. Following this transact...

2023-11-20 20:04 2768

Porton Advanced and Ascle Therapeutics Reached a Strategic Partnership to Promote the Application of NK Cells in Cancer Prevention, Beauty, and Anti-aging

SUZHOU, China, Nov. 20, 2023 /PRNewswire/ -- On November 20, 2023, Porton Advanced announced a strategic partnership with Ascle Therapeutics to jointly develop and produce NK cells, assist in the development and innovation in gene and cell therapy, and accelerate the application of NK cells in ca...

2023-11-20 20:00 1220

Prenetics Announces Third Quarter 2023 Financial Results

HONG KONG, Nov. 20, 2023 /PRNewswire/ -- Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading genomics-driven health sciences company, today announced financial results for the third quarter endedSeptember 30, 2023, along with recent business updates. Third Quarter 20...

2023-11-20 19:30 2323

TSI Group Joins Halma Group, Unveiling New Avenues for Growth

SUGAR LAND, Texas, Nov. 20, 2023 /PRNewswire/ -- TeDan Surgical Innovations, a leading player in the medical technology sector, is thrilled to announce its inclusion in the Halma Group. This strategic move marks the formation of the TSI Group, which is comprised of TeDan Surgical Innovations, Wes...

2023-11-20 19:00 1915

First Subject Enrolled in Phase 1 Study of MRX-5

SHANGHAI, Nov. 20, 2023 /PRNewswire/ -- Recently, Shanghai MicuRx Pharmaceuticals Co., Ltd. (hereinafter referred to as "MicuRx") announced that its proprietary antibiotic MRX-5, has enrolled its first subject in the first Phase I clinical trial inAustralia. MRX-5 is a new type of benzodiazepine...

2023-11-20 18:34 1460

GCCL Wins Top 10 Bioanalytical Services Providers in APAC 2023

Recognized for its global-quality sample analysis services based on various analytical platforms YONGIN, South Korea, Nov. 20, 2023 /PRNewswire/ -- GCCL, a Korean clinical trial sample analysis company, announced onNovember 20th that it has been selected as the Top 10 Bioanalytical Services Prov...

2023-11-20 14:39 1432

Venus Medtech's Exciting Innovations for Structural Heart to Be Showcased at London Valves 2023

The company will be presenting its growing pipeline of superb technologies for treating all four heart valves in its booth and at multiple events during the conference. HANGZHOU, China, Nov. 20, 2023 /PRNewswire/ -- Venus Medtech is changing how the world treats structural heart disease. The com...

2023-11-20 07:09 2070

Sanyou's "STAL Platform" is a significant advancement in the field of drug discovery.

SHANGHAI, Nov. 17, 2023 /PRNewswire/ -- Sanyou's "STAL Innovative Biologics Drug Discovery Platform" is a significant advancement in the field of drug discovery. This cutting-edge platform enables the screening of thousands of innovative lead molecules against a common target, surpassing the capa...

2023-11-18 08:00 3083

CytoMed Therapeutics Reports First Half 2023 Financial Report and Provides Corporate Update

Conference call webcast is scheduled for November 22 at 9 a.m. ET. SINGAPORE, Nov. 17, 2023 /PRNewswire/ -- CytoMed Therapeutics Limited (NASDAQ: GDTC) ("CytoMed" or "Company"), a Singapore -based biopharmaceutical company focused on harnessing its proprietary technologie...

2023-11-17 22:21 3766

Oncoclínicas has Net Profit of R$149 million (162% higher vs 3Q22) and Gross Revenue of R$1.5 billion in the third quarter

Operating Cash Generation was R$322 million, a record for the company's third quarter SÃO PAULO, Nov. 17, 2023 /PRNewswire/ -- Oncoclínicas & Co. (B3: ONCO3) reported a 23.4% increase in its gross revenue in the third quarter of 2023, reachingR$1.5 billion, another record for the company. The pe...

2023-11-17 22:10 2313

The Institute of Human Genetics, Polish Academy of Sciences (IHG PAS) is Live on SOPHiA GENETICS

The SOPHiA DDM™ Platform used by IHG PAS to advance its research of male infertility BOSTON and ROLLE, Switzerland, Nov. 17, 2023 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced that the Institute of Human Gene...

2023-11-17 21:02 1650

Meihua International Medical Technologies Co. Unveils Speed Fox, a Cutting-Edge AI-Powered Warehouse Management and Medical Device Logistics Platform

YANGZHOU, China, Nov. 17, 2023 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ: MHUA), a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries inChina, announced today the upcoming la...

2023-11-17 21:00 1439

Taiwan Lubricate for academic research and health products development

TAICHUNG, Nov. 17, 2023 /PRNewswire/ -- Based in Taiwan, T-BAL is the leading service provider in measurements of lipids and metabolites for both academics and industry. In the collaboration with Lipotype GmbH,Germany (the world leader in lipidomics profiling service), T-BAL has developed advance...

2023-11-17 20:00 1248

Singleron Biotechnologies announces two co-authored abstracts at the American Society of Hematology conference

Using single cell multi-omics analysis to predict treatment outcome, develop disease prognostics and track patient responses to CAR T therapies COLOGNE, Germany, Nov. 17, 2023 /PRNewswire/ -- Singleron Biotechnologies , a company at the forefront of developing and commerc...

2023-11-17 17:58 1413

epitoMAP Inc., Animal Allergy Clinical Laboratories Inc. and Nippon Zenyaku Kogyo Co., Ltd. Enter into License Agreement

SAGAMIHARA, Japan, Nov. 17, 2023 /PRNewswire/ -- epitoMAP Inc. (hereinafter "epitoMAP") and Animal Allergy Clinical Laboratories Inc. (hereinafter "AACL") entered into a License Agreement for an antibody pharmaceutical for veterinary use, CRE-DR-B, with Nippon Zenyaku Kogyo Co., Ltd. (hereinafter...

2023-11-17 16:00 1386

Fosun International Wins "Best in ESG Practices" and "Best in ESG Report" at TVB ESG Awards 2023

HONG KONG, Nov. 17, 2023 /PRNewswire/ -- On 9 November 2023, the TVB ESG Awards 2023 (the "Awards"), organized by Television Broadcasts Limited ("TVB") was held at the Hong Kong Convention and Exhibition Center. Fosun International was honored with "Best in ESG Practices" and "Best in ESG Report"...

2023-11-17 15:23 3196

WuXi XDC Successfully Listed on the Main Board of Hong Kong Stock Exchange

HONG KONG, Nov. 17, 2023 /PRNewswire/ -- WuXi XDC Cayman Inc. ("WuXi XDC" or the "Company", stock code: 2268.HK), a leading global Contract Research, Development and Manufacturing Organization ("CRDMO") focused on antibody drug conjugates ("ADC") and the broader bioconjugate market, listed on the...

2023-11-17 14:00 2987

Over 86 percent of Thai and Indonesian Women Consider Thalassemia Screening after Learning about Associated Health Risks

Thai (91.2%) and Indonesian (86.6%) women consider screening after learning about health risks and costs which is higher than the global average of 84.5% BANGKOK, Nov. 17, 2023 /PRNewswire/ -- According to Thailand's Ministry of Public Health , ...

2023-11-17 08:22 2093

Antengene Presents Encouraging Clinical Data from Four Pipeline Programs at the 2023 R&D Day

* Clinical programs, including ATG-101 (PD-L1/4-1BB bispecific antibody), ATG-022 (Claudin 18.2 antibody-drug conjugate), and ATG-037 (oral CD73 inhibitor) have shown clinical responses in cancer patients with advanced diseases. * ATG-008 (dual mTORC1/2 inhibitor) continued showing strong cli...

2023-11-17 08:00 2114

Lunit to Implement AI-Powered Chest Screening Solution in Five Major Saudi Hospitals

-    Lunit brings Lunit INSIGHT CXR to five major Saudi hospitals, aiming to enhance early detection of common lung abnormalities and improve patient outcomes in line with the national health strategy SEOUL, South Korea, Nov. 16, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of ...

2023-11-16 22:00 1696
1 ... 121122123124125126127 ... 611

Week's Top Stories